首页> 美国卫生研究院文献>Clinical Ophthalmology (Auckland N.Z.) >Is reduction in the risk of vision loss the only benefit of photodynamic therapy in predominantly classic subfoveal choroidal neovascularization?

【2h】

Is reduction in the risk of vision loss the only benefit of photodynamic therapy in predominantly classic subfoveal choroidal neovascularization?

机译：在主要的黄斑下凹脉络膜新生血管形成中降低视力丧失风险是否是光动力疗法的唯一好处？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

PurposeTo emphasize the effect of photodynamic therapy (PDT) on the size and progression of the neovascular lesion (NL) and evolution of the disciform scar (DS) in predominantly classic subfoveal choroidal neovascularization (SFCNV).

机译：目的强调光动力疗法（PDT）对主要为黄斑下凹脉络膜新生血管（SFCNV）的新生血管病变（NL）的大小和进展以及盘状疤痕（DS）的演变的影响。

著录项

期刊名称 Clinical Ophthalmology (Auckland N.Z.)
作者
Nicola G Ghazi; Brian P Conway; James S Tiedeman; Steven J Yoon;
展开▼
作者单位

展开▼
年(卷),期 2008(2),4
年度 2008
页码 773–780
总页数 8
原文格式 PDF
正文语种
中图分类眼科学;
关键词
age-related macular degeneration choroidal neovascularization classic choroidal neovascularization disciform scarring fluorescein angiography photodynamic therapy;

机译：年龄相关性黄斑变性;脉络膜新生血管;经典脉络膜新生血管;盘状瘢痕;荧光素血管造影术;光动力疗法;

相似文献

外文文献
中文文献
专利

1. Is reduction in the risk of vision loss the only benefit of photodynamic therapy in predominantly classic subfoveal choroidal neovascularization? [J] . Nicola G Ghazi, rian P Conway, James S Tiedeman, Clinical ophthalmology . 2008,第4期

机译：在主要的黄斑下凹脉络膜新生血管形成中，减少视力丧失的风险是否是光动力疗法的唯一好处？
2. Optical Coherence Tomography Following Photodynamic Therapy With Verteporfin for Subfoveal Predominantly Classic Choroidal Neovascularization [J] . CARL-H. PARK, _BRADLEY-T. SMITH, MILA OH, Annals of Ophthalmology . 2007,第2期

机译：Verteporfin光动力疗法治疗小凹下主要为经典脉络膜新生血管的光学相干断层扫描
3. Optical Coherence Tomography Following Photodynamic Therapy With Verteporfin for Subfoveal Predominantly Classic Choroidal Neovascularization [J] . CARL H. PARK, BRADLEY T. SMITH, SHARON FEKRAT Annals of Ophthalmology . 2006,第2期

机译：Verteporfin光动力疗法治疗小凹下主要为经典脉络膜新生血管的光学相干断层扫描
4. Therapeutic response of experimental choroidal neovascularization in mice with photodynamic/photothermal therapy using ICG loaded gold nanorods as a photosensitizer [C] . Rupesh Singh, Julia C. Batoki, Bela Anand-Apte International Photodynamic Association World Congress . 2019

机译：用ICG负载金纳米杆作为光敏剂对小鼠实验脉络膜新生血管形成的疗效
5. A model for choroidal neovascularization (CNV) and gene therapy for age-related macular degeneration (AMD). [D] . Wang, Fei. 2001

机译：脉络膜新生血管（CNV）和年龄相关性黄斑变性（AMD）基因治疗的模型。
6. Photodynamic therapy in non‐subfoveal choroidal neovascularization secondary to pathological myopia: 1‐year outcome [O] . Juan Reche‐Frutos, Cristina Calvo‐González, Juan Donate‐López, 2007

机译：继发于病理性近视的非中心凹脉络膜新生血管的光动力疗法：1年结局
7. Is reduction in the risk of vision loss the only benefit of photodynamic therapy in predominantly classic subfoveal choroidal neovascularization? [O] . Ghazi, Nicola G, Conway, Brian P, Tiedeman, James S, 2008

机译：在主要的黄斑下凹脉络膜新生血管形成中，降低视力丧失风险是否是光动力疗法的唯一好处？
8. Measuring Property Management Risk and Loss: Step One Toward Managing Property on a Foundation of Risk, Cost, and Benefit;The Property Professional [R] . Johnson, C. 1999

机译：衡量物业管理风险与损失：在风险，成本和效益基础上管理物业的第一步;物业专业人员

Is reduction in the risk of vision loss the only benefit of photodynamic therapy in predominantly classic subfoveal choroidal neovascularization?

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅